Pituitary tumours: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• TP53 0
• BRAF 0
• CTNNB1 0
• MGMT 1
• PD-1 0
• PI3K 0
• PSMA 0
• AKT 0
• CTLA-4 0
• CXCR4 0
• HSP90 0
• MEK 0
• MYC 0
• MYCN 0
• SGLT2 0
• SIRT1 0
• STING 0

24 of 454 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NCI · R01

  A novel function of prolactin signaling in brain metastasis in HER2-positive breast cancer

  Columbia University Health Sciences· New York, United States· US$448,017 awarded in fiscal year 2026· until Jul 2031

• NIH NCI · R01

  Towards Safe and Efficacious Medical Therapy for Patients with Clinically Non-Functioning Pituitary Tumors

  University of California Los Angeles· Los Angeles, United States· US$475,401 awarded in fiscal year 2026· until May 2029

• NIH NIDDK · R01

  The Role of O-GlcNAcylation in Corticotroph Physiology and Disease

  Medical College of Wisconsin· Milwaukee, United States· US$694,092 awarded in fiscal year 2026· until Mar 2030

• NIH NIDDK · R01

  Advancing Targeted Therapies for Cushing's Disease Using Pituitary Neuroendocrine Tumor Organoids

  University of Georgia· Athens, United States· US$3,162,826 awarded in fiscal year 2025· until Aug 2029

• NIH NCI · R21

  Somatostatin Receptor 2 Expression in Pituitary Neuroendocrine Tumors as a Basis for PET/MRI guided Subtype Stratification and Radiotherapy Planning

  Weill Medical Coll of Cornell Univ· New York, United States· US$196,086 awarded in fiscal year 2026· until Mar 2027

5 of 15 running projects, newest first. Listed amounts together: US$13.3m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

• An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  NCT00001595· Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)· Source

• Managing Pasireotide-associated Hyperglycaemia in Acromegaly With Ketogenic Diet

  NCT07866846· Leiden University Medical Center· Source

• Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery

  NCT07316101· West China Hospital· Source

• Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

  NCT04042753· Memorial Sloan Kettering Cancer Center· Source

• Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

  NCT07595666· prof. dr. Koen Van Laere· Source

• AI in Endoscopic Transsphenoidal Surgery

  NCT07568366· University College, London· Source

• Safety and Potency of a High Cabergoline Dosage in Microprolactinomas

  NCT07463235· University of Sao Paulo General Hospital· Source

• A Study of Pasireotide in People With Prolactinoma

  NCT06295952· Memorial Sloan Kettering Cancer Center· Source

• NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After Endonasal Skull Base Surgery

  NCT07216157· Maria Sklodowska-Curie National Research Institute of Oncology· Source

• Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas

  NCT07015645· Al-Azhar University· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 6
• Organoids 3
• Mendelian Randomization Analysis 1
• Gene Expression Profiling 8
• Sequence Analysis, RNA 1
• Exome Sequencing 2
• Proteomics 9
• Metabolomics 3
• Flow Cytometry 1
• Immunohistochemistry 16
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 3
• Positron-Emission Tomography 9
• Magnetic Resonance Imaging 156
• Machine Learning 13
• Deep Learning 11
• Cohort Studies 32
• Genome-Wide Association Study 1

See which targets of this disease your abstract mentions, and go to the people working on them.